Phaos Technology Holdings (Cayman) (POAS) Equity Average (2025)
Phaos Technology Holdings (Cayman) (POAS) reported Equity Average of -$2.5 million for Q4 2025, down 805.99% quarter-over-quarter from $349908.4 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Equity Average (2025) Analysis & Trends
Phaos Technology Holdings (Cayman) has reported Equity Average for 1 years, with the latest figure at -$2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Average changed N/A year-over-year to -$2.5 million; the trailing twelve-month figure through Oct 2025 stood at -$2.5 million (changed N/A YoY), and the FY2025 full-year result was $349236.0, changed N/A from the prior year.
- Equity Average for Q4 2025 stood at -$2.5 million, down from $349908.4 in the prior quarter.
- The five-year high for Equity Average was $349908.4 in Q2 2025, with the low at -$2.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.05 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 682,234.12 | 627,245.12 | - | -2.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -2.47 Mn |
| Apr 30, 2025 | 349,908.44 |